Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of gemigliptin 50 mg on diabetic retinopathy in type 2 diabetes
KCT0002681Phase 4Recruiting
- Sponsor
- LG Chem
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gemigliptin in diabetic retinopathy (DR) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by LG Chem. Started Aug 2017; status: recruiting.
02
Drugs
gemigliptin
03
Conditions
diabetic retinopathy (DR)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on KCT0002681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002681.